What is the Impact Factor of Acta Diabetologica?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Acta Diabetologica is 3.10, ranking in quartile Q3 of Web of Science (SCIE).

Is Acta Diabetologica indexed in Web of Science or Scopus?

Yes, Acta Diabetologica is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.011 (Q1) and an H-index of 93.

Who publishes Acta Diabetologica and what is the Article Processing Charge (APC)?

Acta Diabetologica is published by Springer Milan. The estimated Article Processing Charge (APC) is approximately $3,358 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Acta Diabetologica?

The official ISO-4 abbreviation of Acta Diabetologica is "ACTA DIABETOL" with common acronym "acdi". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q1SCImago #4,819Hybrid

Acta Diabetologica

Acronym:acdi

•

Abbreviation (ISO):ACTA DIABETOL

•

Identifier (ISSN):0940-5429(Print)/1432-5233(Online)

•

Publisher:Springer Milan

Official Website Submission Portal Compare

Clarivate IF (2026)

3.1↑ +0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Acta Diabetologica

WoS Q3

Annual Impact Factor Metric

Current (2026):3.1

Scopus SJR & RankScopus Q1

1.011

#4,819

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

93 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate3.2%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

168articles/year

34.02% Gold OA•89.63% Original Research

Aims & Scope

Acta Diabetologica is a journal that publishes reports of experimental and clinical research on diabetes mellitus and related metabolic diseases. Original contributions on biochemical, physiological, pathophysiological and clinical aspects of research on diabetes and metabolic diseases are welcome. Reports are published in the form of original articles, short communications and letters to the editor. Invited reviews and editorials are also published. A Methodology forum, which publishes contributions on methodological aspects of diabetes in vivo and in vitro, is also available. The Editor-in-chief will be pleased to consider articles describing new techniques (e.g., new transplantation methods, metabolic models), of innovative importance in the field of diabetes/metabolism. Finally, workshop reports are also welcome in Acta Diabetologica.

Topics Covered (Recognized by AI)

Medicine96.6%Biology92.1%Endocrinology88.5%Diabetes mellitus83.7%Internal medicine81.8%Pathology50.1%Chemistry46.3%Biochemistry43.6%Genetics40.4%Biotechnology39.2%Insulin38.7%Type 2 diabetes34.3%Surgery22.4%Mathematics21.6%

Primary Research Areas

Medicine Endocrinology & Metabolism

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Rank105/198

IndexSCIE

JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Rank106/198

IndexSCIE

Category	Index	Rank	Quartile
ENDOCRINOLOGY & METABOLISM	JCRSCIE	105/198	Q3
ENDOCRINOLOGY & METABOLISM	JCISCIE	106/198	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.1

Articles / Year166

Total Citations38

2025

IF2.9

Articles / Year189

Total Citations510

2024

IF3.1

Articles / Year211

Total Citations1,080

2023

IF3.8

Articles / Year198

Total Citations1,934

2022

IF4.087

Articles / Year190

Total Citations2,334

Year	Impact Factor	Articles / Year	Total Citations
2026	3.1	166	38
2025	2.9	189	510
2024	3.1	211	1,080
2023	3.8	198	1,934
2022	4.087	190	2,334
2021	4.28	188	3,770
2020	3.418	172	4,567
2019	2.996	193	4,815
2018	3.126	182	5,712
2017	—	133	4,249
2016	—	125	3,437
2015	—	127	3,980

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,819Scopus Q1SCImago Profile

Scopus Coverage:1991-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

1.011

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.44

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,358 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,698

3-Year Documents526

Citable Documents491

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate51.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1

EndocrinologyQ2

Endocrinology, Diabetes and MetabolismQ2

Internal MedicineQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ENDOCRINOLOGY & METABOLISM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Acta Diabetologica (acronym: acdi, abbr: ACTA DIABETOL, ISSN: 0940-5429) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Milan in Italy since 1964. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 1.011 (Q1), an H-index of 93.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 168 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,358 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.